Nalaganje...

Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response

Amyloid light chain (AL) amyloidosis is a systemic disease characterised by the aggregation of misfolded immunoglobulin light chain (LC), predominantly in the heart and kidneys, causing organ failure. If untreated, the median survival of patients with cardiac AL amyloidosis is 6 months from the onse...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Heart
Main Authors: Grogan, Martha, Dispenzieri, Angela, Gertz, Morie A
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2017
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5566095/
https://ncbi.nlm.nih.gov/pubmed/28456755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/heartjnl-2016-310704
Oznake: Označite
Brez oznak, prvi označite!